| Akt as a target for cancer therapy: more is not always better (lessons from studies in mice) Q Wang, X Chen, N Hay British journal of cancer 117 (2), 159-163, 2017 | 131 | 2017 |
| Spontaneous hepatocellular carcinoma after the combined deletion of Akt isoforms Q Wang, WN Yu, X Chen, X Peng, SM Jeon, MJ Birnbaum, G Guzman, ... Cancer cell 29 (4), 523-535, 2016 | 104 | 2016 |
| A human multi-lineage hepatic organoid model for liver fibrosis Y Guan, A Enejder, M Wang, Z Fang, L Cui, SY Chen, J Wang, Y Tan, ... Nature communications 12 (1), 6138, 2021 | 59 | 2021 |
| The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy Y Guan, X Chen, M Wu, W Zhu, A Arslan, S Takeda, MH Nguyen, R Majeti, ... Journal of hepatology 72 (4), 746-760, 2020 | 37 | 2020 |
| Cell-autonomous versus systemic Akt isoform deletions uncovered new roles for Akt1 and Akt2 in breast cancer X Chen, MM Ariss, G Ramakrishnan, V Nogueira, C Blaha, W Putzbach, ... Molecular cell 80 (1), 87-101. e5, 2020 | 22 | 2020 |
| Analysis of structural variation among inbred mouse strains A Arslan, Z Fang, M Wang, Y Tan, Z Cheng, X Chen, Y Guan, L J. Pisani, ... BMC genomics 24 (1), 97, 2023 | 8 | 2023 |
| High throughput computational mouse genetic analysis A Arslan, Y Guan, Z Fang, X Chen, R Donaldson, W Zhu, M Ford, M Wu, ... BioRxiv, 2020.09. 01.278465, 2020 | 8 | 2020 |
